Sesquiterpenoids and 2-(2-phenylethyl)chromones respectively acting as α-glucosidase and tyrosinase inhibitors from agarwood of an Aquilaria plant

The ethyl ether extract of agarwood from an Aquilaria plant afforded six new sesquiterpenoids, Agarozizanol A - F (1-6), together with four known sesquiterpenoids and six known 2-(2-phenylethyl)chromones. Their structures were elucidated via detailed spectroscopic analysis, X-ray diffraction, and comparisons with the published data. All the isolates were evaluated for the α-glucosidase and tyrosinase inhibitory activities in vitro. Compounds 5, 7, 8, and 10 showed significant inhibition of α-glucosidase with IC50 values ranging between 112.3 ± 4.5 and 524.5 ± 2.7 µM (acarbose, 743. 4 ± 3.3 µM). Compounds 13 and 14 exhibited tyrosinase inhibitory effect with IC50 values of 89.0 ± 1.7 and 51.5 ± 0.6 µM, respectively (kojic acid, 46.1 ± 1.3). In the kinetic studies, compounds 5 and 14 were found to be uncompetitive inhibitors for α-glucosidase and mixed type inhibitors for tyrosinase, respectively. Furthermore, molecular docking simulations revealed the binding sites and interactions of the most active compounds with α-glucosidase and tyrosinase.

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:34

Enthalten in:

Journal of enzyme inhibition and medicinal chemistry - 34(2019), 1 vom: 01. Dez., Seite 853-862

Sprache:

Englisch

Beteiligte Personen:

Yang, Li [VerfasserIn]
Yang, Yi-Ling [VerfasserIn]
Dong, Wen-Hua [VerfasserIn]
Li, Wei [VerfasserIn]
Wang, Pei [VerfasserIn]
Cao, Xue [VerfasserIn]
Yuan, Jing-Zhe [VerfasserIn]
Chen, Hui-Qin [VerfasserIn]
Mei, Wen-Li [VerfasserIn]
Dai, Hao-Fu [VerfasserIn]

Links:

Volltext

Themen:

α-glucosidase inhibition
2-(2-phenylethyl)chromone
Agarwood
Aquilaria plant
Chromones
EC 1.14.18.1
Enzyme Inhibitors
Glycoside Hydrolase Inhibitors
Journal Article
Monophenol Monooxygenase
Sesquiterpenes
Sesquiterpenoid
Tyrosinase inhibition

Anmerkungen:

Date Completed 01.05.2019

Date Revised 25.02.2020

published: Print

Citation Status MEDLINE

doi:

10.1080/14756366.2019.1576657

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM296306878